Clinical Trial Update: Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary Heart Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating a cardiac metabolic modulator for improving diastolic function in patients with coronary heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Diastolic Dysfunction

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Coronary Heart Disease, Diastolic Dysfunction | Phase 4 | Status: UNKNOWN